(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of -0.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Rxsight's revenue in 2025 is $148,310,000.On average, 5 Wall Street analysts forecast RXST's revenue for 2025 to be $5,106,280,485, with the lowest RXST revenue forecast at $5,087,750,021, and the highest RXST revenue forecast at $5,125,948,783. On average, 5 Wall Street analysts forecast RXST's revenue for 2026 to be $5,463,479,548, with the lowest RXST revenue forecast at $4,986,157,569, and the highest RXST revenue forecast at $5,802,960,887.
In 2027, RXST is forecast to generate $6,012,566,435 in revenue, with the lowest revenue forecast at $5,445,355,454 and the highest revenue forecast at $6,855,458,695.